Cerebrospinal fluid markers of neuroinflammation in delirium: A role for interleukin-1β in delirium after hip fracture

Journal of Psychosomatic Research

Volumn 77, Issue 3, 2014, Pages 219-225

  Cape, Eleanor ^a   Hall, Roanna J ^a,b   van Munster, Barbara C ^c,d   de Vries, Annick ^e   Howie, Sarah E M ^a   Pearson, Andrew ^a   Middleton, Scott D ^f   Gillies, Fiona ^a   Armstrong, Ian R ^f   White, Tim O ^f   Cunningham, Colm ^g   de Rooij, Sophia E ^c   MacLullich, Alasdair M J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cerebrospinal fluid; Delirium; Inflammation; Interleukin 1 receptor antagonist; Interleukin 1

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FEMUR NECK FRACTURE; HIP ARTHROPLASTY; HIP FRACTURE; HUMAN; LIMIT OF DETECTION; MALE; NERVOUS SYSTEM INFLAMMATION; OSTEOSYNTHESIS; PERIPROSTHETIC FRACTURE; POSTOPERATIVE PERIOD; SPINAL ANESTHESIA;

CEREBROSPINAL FLUID; DELIRIUM; INFLAMMATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; INTERLEUKIN-1Β;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DELIRIUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIP FRACTURES; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED;

EID: 84906790808     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2014.06.014     Document Type: Article

References (71)

1. Young J, Inouye S Delirium in older people. Br Med J 2008, 334:842-846.
2. Murray C, Sanderson D, Barkus C, Deacon R, Rawlins J, Bannerman D, et al. Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol Aging 2012, 33:603-616.
3. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 2008, 22:301-311.
4. Barrientos R, Higgins E, Biedenkapp J, Sprunger D, Wright-Hardesty K, Watkins L, et al. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 2006, 27:723-732.
5. Griffin E, Skelly D, Murray C, Cunningham C Cyclooxygenase-1 dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J Neurosci 2013, 33:15248-15258.
6. van Munster B, Korevaar J, Zwinderman A, Levi M, Wiersinga W, De Rooij S Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 2008, 56:1704-1709.
7. de Rooij S, van Munster B, Korevaar J, Levi M Cytokines and acute phase response in delirium. J Psychosom Res 2007, 62:521-525.
8. Adamis D, Lunn M, Martin FC, Treloar A, Gregson N, Hamilton G, et al. Cytokines and IGF-1 in delirious and non-delirious acutely ill older medical inpatients. Age Ageing 2009, 38:326-332.
9. Wilson K, Broadhurst C, Diver M, Jackson M, Mottram P Plasma insulin-like growth factor-1 and incident delirium. Int J Geriatr Psychiatry 2005, 20:154-159.
10. MacLullich A, Edelshain B, Hall R, de Vries A, Howie S, Pearson A, et al. Cerebrospinal IL-8 levels are higher in hip fracture patients with delirium versus controls. J Am Geriatr Soc 2011, 59:1151-1153.
11. Konsman J, Parnet P, Dantzer R Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002, 25:154-159.
12. Goshen I, Yirmiya R Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009, 30:30-45.
13. Skinner R, Gibson R, Rothwell N, Pinteaux E, Penny J Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 2009, 156:1115-1123.
14. Banks W, Ortiz L, Plotkin S, Kastin A Human interleukin (IL) 1 alpha murine IL-1a and murine IL-1b are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991, 259:988-996.
15. Rigor R, Beard RJ, Litovka O, Yuan S Interleukin-ib-induced barrier dysfunction is signaled through pkc-o in human brain microvascular endothelium. Am J Physiol Cell Physiol 2012, 302:C1513-C1522.
16. Raison C, Capuron L, Miller A Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
17. Cunningham C, Wilcockson D, Campion S, Lunnon K, Perry V Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005, 25:9275-9284.
18. MacLullich A, Ferguson K, Miller T, de Rooij S, Cunningham C Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 2008, 65:229-238.
19. Perry V, Cunningham C, Holmes C Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 2007, 7:161-167.
20. Association, American Psychiatric: [dsm iv tr], 2000.
21. Inouye S, Vandyck C, Alessi C, Balkin S, Siegal A, Horowitz R Clarifying confusion - the confusion assessment method - a new method for detection of delirium. Ann Intern Med 1990, 113.
22. Jorm A, Jacomb P The informant questionnaire on cognitive decline in the elderly (iqcode) - socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989, 19:1015-1022.
23. Harwood D, Hope T, Jacoby R Cognitive impairment in medical inpatients. I: screening for dementia - is history better than mental state?. Age Ageing 1997, 26:31-35.
24. Charlson M, Pompei P, Ales K, MacKenzie C A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
25. Mehta P, Kulczycki J, Mehta S, Coyle P, Wisniewski H Increased levels of interleukin-1b and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Infect Dis 1997, 175:689-692.
26. Dujmovic I, Mangano K, Pekmezovic T, Quattrocchi C, Mesaros S, Stojsavljevic N, et al. The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type ii after steroid therapy. J Neuroimmunol 2009, 207:101-106.
27. Lampa J, Westman M, Kadetoff D, Nordenstedt Agreus A, Le Maitre E, Gillis-Haegerstrand C, et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. PNAS 2012, 109:12728-12733.
28. Sun Y, Lu C-J, Lin C-H, Wen L-L Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts. Eur J Neurol 2009, 16:858-863.
29. Lanzrein A-S, Johnston C, Perry V, Jobst K, King E, Smith A Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumour necrosis factor-alpha, the soluble tumour necrosis factor receptors i and ii, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 1998, 12:215-227.
30. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, et al. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?. J Psychiatr Res 2005, 39:535-543.
31. Tarkowski E, Blennow K, Wallin A, Tarkowski A Intracerebral production of tumor necrosis factor-a, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 1999, 19:223-230.
32. Gomez-Tortosa E, Gonzalo I, Fanjul S, Sainz M, Cantarero S, Cemillan C, et al. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease. Arch Neurol 2003, 60:1218-1222.
33. Bociaga-Jasik M, Garlicki A, Ciesla A, Kalinowska-Nowak A, Sobczyk-Krupiarz I, Mach T The diagnostic value of cytokine and nitric oxide concentrations in cerebrospinal fluid for the differential diagnosis of meningitis. Adv Med Sci 2012, 57:142-147.
34. Beran O, Lawrence D, Andersen N, Dzupova O, Kalmusova J, Musilek M, et al. Sequential analysis of biomarkers in CSF and serum during invasive meningococcal disease. Eur J Clin Microbiol Infect Dis 2009, 28:793-799.
35. Asaoka K, Shoji H, Nishizaka S, Ayabe M, Abe T, Ohori N, et al. Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Intern Med 2004, 43:42-48.
36. Tarkowski E, Andreasen N, Tarkowski A, Blennow K Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003, 74:1200-1205.
37. Kalita J, Srivastava R, Mishra M, Basu A, Misra U Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett 2010, 473:48-51.
38. Vitkovic L, Bockaert J, Jacque C "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem 2000, 74:457-471.
39. Cibelli M, Fidalgo A, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of interleukin-1 beta in postoperative cognitive dysfunction. Ann Neurol 2010, 68:360-368.
40. Konsman J, Kelley K, Dantzer R Temporal and spatial relationships between lipopolysaccharide-induced expression of fos, interleukin-1 beta and inducible nitric oxide synthase in rat brain. Neuroscience 1999, 89:535-548.
41. Davies C, Loddick S, Toulmond S, Stroemer R, Hunt J, Rothwell N The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1999, 19:87-98.
42. Spulber S, Bartfai T, Schultzberg M Il-1/il-1ra balance in the brain revisited - evidence from transgenic mouse models. Brain Behav Immun 2009, 23:573-579.
43. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Clin Exp Immunol 1997, 110:492-499.
44. Rothwell N, Luheshi G Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000, 23:618-625.
45. Abraham J, Johnson RW Central inhibition of interleukin-1 beta ameliorates sickness behavior in aged mice. Brain Behav Immun 2009, 23:396-401.
46. Dantzer R, Kelley K Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21:153-160.
47. Cunningham C, MacLullich A At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun 2013, 28:1-13.
48. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging 2008, 29:1744-1753.
49. Kelley K, Bluthe R-M, Dantzer R, Zhou J-H, Shen W-H, Johnson R, et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003, 17:S112-S118.
50. Pearson A, de Vries A, Middleton S, Gillies F, White T, Armstrong I, et al. Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes 2010, 3.
51. Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L, et al. Brain interleukin 1 and s-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1989, 86:7611-7615.
52. Griffin W, Mrak R Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 2002, 72:233-238.
53. Allan S, Tyrrell P, Rothwell N Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640.
54. Loddick S, Wong M-L, Bongiorno P, Gold P, Licinio J, Rothwell N Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun 1997, 234:211-215.
55. Bartfai T, Sanchez-Alavez M, Andell-Jonsson A, Schultzberg M, Vezzani A, Danielsson E, et al. Interleukin-1 system in CNS stress; seizures, fever, and neurotrauma. Ann N Y Acad Sci 2007, 1113:173-177.
56. Clinical Trials Register E https://www.Clinicaltrialsregister.Eu/ctr-search/search?Query=il-1ra.
57. Galea J, Ogungbenro K, Hulme S, Greenhalgh A, Aarons L, Scarth S, et al. Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab 2011, 31:439-447.
58. Gouze J-G, Gouze E, Palmer G, Liew V, Pascher A, Betz O, et al. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Arthritis Res Ther 2003, 5:R301-R309.
59. Arend W, Welgus H, Thompson R, Eisenberg S Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Investig 1990, 85:1694-1697.
60. Mashayekhi F, Mirzajani E, Naji M, Azari M Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease. J Clin Neurosci 2010, 17:623-627.
61. Salehi Z, Mashayekhi F, Naji M Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease. Biofactors 2008, 33:99-106.
62. Ferrari T, Moreira P, Sampaio M, da Cunha A, de Oliveira J, Gazzinelli G, et al. Intrathecal cytokines in spinal cord schistosomiasis. J Neuroimmunol 2006, 177:136-141.
63. Fassbender K, Mielke O, Bertsch T, Muehlhauser F, Hennerici M, Kurimoto M, et al. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999, 53:1104-1106.
64. Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol Sci 2006, 27:33-39.
65. Allan S, Rothwell N Inflammation in CNS injury. Philos Trans R Soc Lond B 2003, 358:1669-1677.
66. van Munster B, Aronica E, Zwinderman A, Eikelenboom P, Cunningham C, de Rooij S Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res 2011, 14:615-622.
67. Axelsson M, Malmestrom C, Nilsson S, Haghighi S, Rosengren L, Lycke J Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 2011, 258:882-888.
68. Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders. Parkinsonism Relat Disord 2010, 16:142-145.
69. Bohmer A, Oses J, Schmidt A, Peron C, Krebs C, Oppitz P, et al. Neuron-specific enolase, s100b, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 2011, 68:1624-1631.
70. Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn P Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischaemic stroke patients. Clin Chem 2010, 56:451-458.
71. Rosengren L, Wikkelso C, Hagberg L A sensitive elisa for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods 1994, 51:197-204.